Asian Brokers: A Competition Between Value and Growth

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Bottom-Up

East Money Information / Equity Bottom-Up

<p>East Money is the most actively traded A-share stock in 2020. It just reported its 1H2021 results. Unlike the traditional broker, it has a strong leverage on its online information platform which is well reflected in its latest financial results. As an unconventional broker and a member stock of the MSCI China A50 index, we think investors should follow the company closely.</p>

East Money is the most actively traded A-share stock in 2020. It just reported its 1H2021 results. Unlike the traditional broker, it has a strong leverage on its online information platform which is well reflected in its latest financial results. As an unconventional broker and a member stock of the MSCI China A50 index, we think investors should follow the company closely.

East Money 1H21: The Most Active A-Share that Beat the Market